Streetbeat News

Revenues

ASLE

AerSale has revised its FY23 revenue guidance to $400M-$420M, down from the estimated $411.11M. The company attributes this to softer demand in the freight market and supply chain issues affecting the availability of USM and flight equipment. The guidance also includes flight equipment sales scheduled to close by year-end, which may shift to Q1 2024 due to transaction volume and tight closing time frames. The guidance does not include potential sales of AerAware, which is awaiting FAA approval.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:47 pm

MCHX

Marchex, a leading provider of call analytics and solutions, anticipates its Q4 revenue to be at or near Q3 levels.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:47 pm

CSTL

Castle Biosciences, Inc. (NASDAQ:CSTL) announced data from a study demonstrating the consistent impact of IDgenetix on medication response and remission rates in patients with major depressive disorder (MDD). The study found that real-world patient outcomes were strongly aligned to the results of a previously published randomized controlled trial (RCT) that demonstrated IDgenetix-guided medication management significantly improved response and remission rates for patients with MDD. The data will be shared at the 2023 Neuroscience Education Institute (NEI) Congress.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:46 pm

BARK

BARK, a pet care company, has projected a revenue growth of between -8% and -11% YoY for FY24.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:45 pm

STKL

SunOpta has projected its revenue for 2024 to be between $670M and $700M, driven by volume and adjusted EBITDA growth. The company has maintained its 2023 outlook, adjusting for the divestiture of its frozen fruit business.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:44 pm

BARK

BARK, a pet product company, has projected its Q3 revenue to be between $119M and $123M, which is significantly lower than the estimated $139.35M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:44 pm

SONX

Sonendo has projected its 2023 revenue to be $44M, slightly below the estimated $44.66M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:43 pm

EBS

Emergent BioSolutions reported Q3 revenue of $270.5M, surpassing the estimate of $237.433M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:40 pm

CDNA

CareDx has projected its FY23 revenue to be between $274M and $278M, which is higher than the estimated $255.42M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:38 pm

SPCE

Virgin Galactic anticipates its Q4 2023 revenue to be approximately $3M.

Portfolio Pulse from Benzinga Newsdesk

November 08, 2023 | 10:38 pm